# Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old

> **NCT02723812** · PHASE4 · COMPLETED · sponsor: **Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products** · enrollment: 120 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** GCFLU® Influenza vaccine (Split virion, Inactivated)

## Key facts

- **NCT ID:** NCT02723812
- **Lead sponsor:** Institute of Clinical Research and Clinical Trial Support for Vaccine and Biological Products
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2016-03-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02723812

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02723812, "Evaluate Safety of GCFLU® Administered Intramuscularly in Healthy Vietnamese Volunteer Aged From 3 Years Old". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02723812. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*